Multicenter prospective cohort study evaluating outcome of COVID-19 in patients with hepatobiliary-pancreatic disease
Not Applicable
Recruiting
- Conditions
- COVID-19 Hepatobiliary-pancreatic disease
- Registration Number
- JPRN-UMIN000040185
- Lead Sponsor
- Keio University School of Medicine, Division of Gastroenterology and Hepatology, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 600
Inclusion Criteria
Not provided
Exclusion Criteria
The following cases willn be excluded from both the control group and the hepatobiliary-pancreatic disease group (1) If the patient requests that they do not wish to cooperate to this study (2) HIV patients (3) Patients with severe other organ failure (4) Patients with advanced cancer of other organs
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method mortality rate
- Secondary Outcome Measures
Name Time Method 1.Rate of patients with severe pneumonia (Requirements of oxygen-support, invasive mechanical ventilation, hospitalization, entering intensive care unit) 2. Time to SARS-CoV-2 RT-PCR negativity 3. Duration of hospitalization